Last reviewed · How we verify

Buprenorphine soluble film

Indivior Inc. · Phase 2 active Small molecule Quality 0/100

Buprenorphine soluble film is a Small molecule drug developed by Indivior Inc.. It is currently in Phase 2 development. Also known as: Subutex.

At a glance

Generic nameBuprenorphine soluble film
Also known asSubutex
SponsorIndivior Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Buprenorphine soluble film

What is Buprenorphine soluble film?

Buprenorphine soluble film is a Small molecule drug developed by Indivior Inc..

Who makes Buprenorphine soluble film?

Buprenorphine soluble film is developed by Indivior Inc. (see full Indivior Inc. pipeline at /company/indivior-inc).

Is Buprenorphine soluble film also known as anything else?

Buprenorphine soluble film is also known as Subutex.

What development phase is Buprenorphine soluble film in?

Buprenorphine soluble film is in Phase 2.

Related